🩸 Risk for MACE/MALE ⬆️w/presence of polyvasc and/or sx/event. 🩸ASA may help, crosses unity line tho 🩸p2y12 helps, modestly - ticag may not be better than clopido
🩸Too bad vorapaxar went away 🩸arterial thrombosis: platelet activation + thrombus (dual pathway inhibition) 🩸Read Compass! Not just #PAD, but CAD (90% had it)=24% RRR on rivaroxaban👊🏾 🩸Voyager: early separation (3m), ongoing divergence. #ACC23
Antithombotics are no joke. More on board = more bleed risk.
🩸#PAD also is no joke. ⬆️⬆️ events. AntiThrombo help ⬇️events 🩸consider adding anticoag to antiplt (voyager/compass) in both PAD and/or CAD 🩸would love to hear thoughts on p2y12i+Xa rather than ASA+Xa #ACC23